Phase III trial planned for drug to reduce brain swelling from stroke
Tuesday, August 23, 2016 - 20:41
in Health & Medicine
Intravenous glyburide, designed to limit brain swelling in stroke patients, did not reduce the number of emergency surgeries in a Phase II clinical trial but did show promise in improving patient outcomes, according to a study published online Aug. 23 in the journal Lancet Neurology. While IV glyburide did not achieve the hoped-for goal in […]